These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 29730600

  • 1. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.
    Luthra P, Burr NE, Brenner DM, Ford AC.
    Gut; 2019 Mar; 68(3):434-444. PubMed ID: 29730600
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC, Brenner DM, Schoenfeld PS.
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ, Sijani F, Brinkman DJ, de Graeff A, Burchell GL, Steegers MAH, van Zuylen L.
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R, Li Z, Huang S, Liu J, Huang J.
    Pain Med; 2020 Nov 01; 21(11):3224-3232. PubMed ID: 32488259
    [Abstract] [Full Text] [Related]

  • 6. Naldemedine versus placebo in opioid-induced constipation: a meta-analysis.
    Wobbe B, Gerner M, Köhne CH.
    BMJ Support Palliat Care; 2024 Jan 08; 13(e3):e578-e584. PubMed ID: 36517204
    [Abstract] [Full Text] [Related]

  • 7. The Management of Opioid-Induced Constipation in Cancer and Advanced Illness: A Meta-Analysis.
    Jesuyajolu DA, Abubakar AK, Kowe T, Ogunlade S, Abioye AI, Tangeman J, Latuga N, Omotayo MO.
    J Pain Symptom Manage; 2024 Apr 08; 67(4):e285-e297. PubMed ID: 38092261
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC.
    Lancet Gastroenterol Hepatol; 2019 Nov 08; 4(11):831-844. PubMed ID: 31474542
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
    Esmadi M, Ahmad D, Hewlett A.
    J Gastrointestin Liver Dis; 2019 Mar 08; 28(1):41-46. PubMed ID: 30851171
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Naldemedine for Opioid-Induced Constipation in Children.
    Miura R, Utano T, Miura Y, Chiba K, Hasegawa A, Takafuji Y, Takahashi H, Tanzawa A, Iwahashi K, Yamatani A, Yotani N.
    J Palliat Med; 2024 Oct 08; 27(10):1354-1358. PubMed ID: 39122251
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC.
    Gut; 2020 Jan 08; 69(1):74-82. PubMed ID: 30996042
    [Abstract] [Full Text] [Related]

  • 12. A meta-analysis of naldemedine for the treatment of opioid-induced constipation.
    Song X, Wang D, Qu X, Dong N, Teng S.
    Expert Rev Clin Pharmacol; 2019 Feb 08; 12(2):121-128. PubMed ID: 30652502
    [Abstract] [Full Text] [Related]

  • 13. A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
    Kamiya T, Imai H, Fujita Y, Hiruta E, Masuno T, Yamazaki S, Tanaka H, Sandoh M, Takei S, Arai K, Nishiba H, Mogi J, Koizuka S, Saito T, Obayashi K, Kaira K, Minato K.
    Medicina (Kaunas); 2023 Mar 02; 59(3):. PubMed ID: 36984494
    [Abstract] [Full Text] [Related]

  • 14. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
    Hale M, Wild J, Reddy J, Yamada T, Arjona Ferreira JC.
    Lancet Gastroenterol Hepatol; 2017 Aug 02; 2(8):555-564. PubMed ID: 28576452
    [Abstract] [Full Text] [Related]

  • 15. Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age.
    Wild J, Webster L, Yamada T, Hale M.
    Drugs Aging; 2020 Apr 02; 37(4):271-279. PubMed ID: 32086791
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mu-opioid antagonists for opioid-induced bowel dysfunction.
    McNicol ED, Boyce D, Schumann R, Carr DB.
    Cochrane Database Syst Rev; 2008 Apr 16; (2):CD006332. PubMed ID: 18425947
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P.
    Curr Pharm Des; 2012 Apr 16; 18(37):6010-20. PubMed ID: 22747544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.